An automated system, also known as an artificial pancreas, designed to help people with Type 1 diabetes control their condition is being developed by theJuvenile Diabetes Research Foundation International (JDRF) in the United States.
The new system would dispense insulin to people with Type 1 diabetes based on real-time changes in blood glucose levels. JDRF has teamed up with the manufacturer and supplier Animas to develop the artificial pancreas, conduct clinical trials for safety, and submit the product to the US Food and Drug Administration for approval.
"Many people with diabetes, including children, are already successfully using external insulin pump therapy, which is designed to remove the need for a daily series of injections, and some also use a continuous blood glucose sensor which monitors blood glucose levels," said Libby Dowling, Care Advisor at Diabetes UK.
"It is ground-breaking that, one day, an artificial pancreas, which would be a combination of an insulin pump and a continuous glucose sensor, could be developed to automatically regulate a person’s blood glucose levels.
Helping prevent complications
"Achieving good blood glucose levels is essential to the management of diabetes and preventing diabetes complications such as blindness, amputation, kidney problems and heart disease.
Similar projects in UK funded by Diabetes UK
“Diabetes UK is funding two similar projects at the University of Cambridge and we hope that this technology will be developed in the UK.”